Genomics' Role in Understanding the Pathogenesis of Endometriosis

review OA: closed CC0 ⤵ 31 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-13

This review discusses recent genomic advances suggesting intrinsic abnormalities in the eutopic endometrium of women with endometriosis contribute to its pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

This paper reviews how genomics and related molecular biology findings have been used to explain endometriosis pathogenesis, focusing on hypothesized intrinsic abnormalities in the eutopic endometrium that may promote processes such as attachment to the peritoneal surface, invasion, implant survival, and vascular supply establishment. It synthesizes evidence from prior molecular studies and gene-expression profiling approaches (including genome-scale approaches and microarray-based studies) discussed in the article. A key limitation acknowledged by the paper is that the precise molecular mechanisms driving attachment, invasion, and establishment of blood supply and survival of implants remain not well understood. This paper is centrally about endometriosis — it specifically discusses how genomics contributes to understanding the condition’s pathogenesis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a benign, estrogen-dependent disorder that has multifactorial components presumed in its pathogenesis. The molecular mechanisms underlying endometrial tissue attachment to the peritoneal surface or metaplasia of the mesothelium, and subsequent invasion and establishment of a blood supply and survival of the endometriotic implants, are not well understood. Recent advances in molecular biology and genomics suggest an intrinsic abnormality in the eutopic endometrium of women with endometriosis that predisposes to these processes. These are discussed herein.
Full text 8,416 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Endometriosis is a benign, estrogen-dependent disorder that has multifactorial components presumed in its pathogenesis. The molecular mechanisms underlying endometrial tissue attachment to the peritoneal surface or metaplasia of the mesothelium, and subsequent invasion and establishment of a blood supply and survival of the endometriotic implants, are not well understood. Recent advances in molecular biology and genomics suggest an intrinsic abnormality in the eutopic endometrium of women with endometriosis that predisposes to these processes. These are discussed herein.

Keywords

Genomics - proteomics - endometrium - implantation - endometriosis

References

- 1 Celera Genomics. The sequence of the human genome. Science . 2001; 291 1304-1351 - 2 Consortium of the IHGS. Initial sequencing and analysis of the human genome. Nature . 2001; 409 813-958 - 3 Schena M, Shalon D, Davis R, Brown P. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science . 1995; 270 467-470 - 4 DeRisi J L, Iyer V R, Brown P O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science . 1997; 278 680-686 - 5 Redwine B D. Was Sampson wrong?. Fertil Steril . 2002; 78 686-693 - 6 Giudice L C, Telles T L, Lobo S, Kao L C. The molecular basis for implantation failure in endometriosis: on the road to discovery. Ann N Y Acad Sci . 2002; 955 252-280 - 7 Witz C A, Cho S, Montoya-Rodriguez I A, Schenken R S. The α2β1 and α3β1 integrins do not facilitate binding of endometrial cells to mesothelium. Fertil Steril . 2002; 78 796-803 - 8 Lessey B A, Metzger D A, Haney A F, McCarty Jr S K. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril . 1989; 49 229-235 - 9 Lessey B A, Damjanovich L, Coutifaris C. et al . Integrin adhesion molecules in the human endometrium: correlation with the normal and abnormal menstrual cycle. J Clin Invest . 1992; 90 188-195 - 10 Barnhart K T, Dunsmoor R, Coutifaris C. The effect of endometriosis on IVF outcome. Fertil Steril . 2000; 74 576-584 - 11 Morcos R N, Gibbons W E, Findley W E. Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: possible role in infertility associated with endometriosis. Fertil Steril . 1986; 44 678-683 - 12 Aeby T C, Huang T, Nakayama R T. The effect of peritoneal fluid from patients with endometriosis on human sperm function in vitro. Am J Obstet Gynecol . 1996; 174 1779-1783 - 13 Oral E, Arici A, Olive D L, Huszar G. Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: the role of seminal fluid components. Fertil Steril . 1996; 66 787-792 - 14 Lessey B A, Castlebaum A J, Sawin S J. et al . Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab . 1994; 79 643-649 - 15 Stewart C L. Leukemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol Reprod Dev . 1994; 39 233-238 - 16 Charnock-Jones D S, Sharkey A M, Fenwick P, Smith S K. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil . 1994; 101 421-426 - 17 Kojima K, Kanzaki H, Iwai M. et al . Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod . 1994; 50 882-887 - 18 Cullinan E B, Abbondanzo S J, Anderson P S. et al . Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci U S A . 1996; 93 3115-3120 - 19 Nachtigall M J, Kliman H J, Feinberg R F. et al . The effect of leukemia inhibitory factor on trophoblast differentiation: a potential role in human implantation. J Clin Endocrinol Metab . 1996; 81 801-806 - 20 Bischof P, Haenggeli L, Campana A. Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol . 1995; 34 225-230 - 21 Tabibzadeh S, Mason J M, Shea W. et al . Dysregulated expression of ebaf, an occult and novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab . 2000; 85 2526-2536 - 22 Taylor H S, Bagot C, Kardana A. et al . HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod . 1999; 14 1328-1331 - 23 Mote P A, Balleine R L, McGowan E M, Clarke C L. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod . 2000; 15 (suppl 3) 48-56 - 24 Mote P A, Balleine R L, McGowan E M, Clarke C L. Co-localization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab . 1999; 84 2963-2971 - 25 Lessey B A, Yeh I, Castelbaum A J. et al . Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril . 1996; 65 477-483 - 26 Kao L C, Tulac S, Lobo S. et al . Global gene profiling in human endometrium during the window of implantation. Endocrinology . 2002; 143 2119-2138 - 27 Carson D D, Lagow E, Thathiah E. et al . Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod . 2002; 8 871-879 - 28 Kao L C, Germeyer A, Tulac S. et al . Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology . 2003; 144 2870-2881 - 29 Taylor R N, Lundeen S G, Giudice L C. Emerging role of genomics in endometriosis research. Fertil Steril . 2002; 78 694-698 - 30 Zeitoun K M, Bulun S E. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril . 1999; 72 961-969 - 31 Zeitoun K M, Takayama K, Michael M D, Bulun S E. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol . 1999; 13 239-253 - 32 Zeitoun K M, Takayama K, Sasano H. et al . Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab . 1998; 83 4474-4480 - 33 Noble L S, Takayama K, Zeitoun K M. et al . Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab . 1997; 82 600-606 - 34 Takayama K, Zeitoun K M, Gunby R T. et al . Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril . 1998; 69 709-713 - 35 Bulun S E, Zeitoun K M, Takayama K. et al . Aromatase as a therapeutic target in endometriosis. Trends Endocrinol Metab . 2000; 11 22-27 - 36 Lebovic D I, Baldocchi R A, Mueller M D, Taylor R N. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril . 2002; 78 849-854 - 37 Eyster K M, Boles A L, Brannian J D, Hansen K A. DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril . 2002; 77 38-42 - 38 Sharpe-Timms K L, Zimmer R L, Ricke E A, Piva M, Horowitz G M. Endometriotic haptoglobin binds to peritoneal macrophages and alters their function in women with endometriosis. Fertil Steril . 2002; 78 810-819 - 39 Khorram O, Taylor R N, Ryan I P, Schall T J, Landers D V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol . 1993; 169 1545-1549 - 40 Lebovic D I, Shifren J L, Ryan I P. et al . Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum Reprod . 2000; 15 (suppl 3) 67-77

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genomics Endometriosis Endometrium Endometrium Female Gene Expression Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (31)

Source provenance

europepmc
last seen: 2026-08-11T06:11:44.160905+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:50.257867+00:00
License: CC0 · commercial use OK